Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 2Nausea 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Deglutition Disorders 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Standard of Care 1Practice Guidelines as Topic 1Platinum 1Granisetron 1Exercise 1Dexamethasone 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1Calcium Dobesilate 1Aprepitant 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Brenner Tumor × auricularum × Clear all
NCT01275664 2018-05-22

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

GOG Foundation

Phase NA Terminated
4 enrolled 5 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡